Pamela L. Simpkins, MBA is a biopharmaceutical business leader with 20+ years of experience in leading strategic initiatives and departments across R&D, corporate strategy, regulatory, marketing, business development and finance. She leads internal and external innovation programs across various therapeutic areas in pharma and devices with special emphasis on public-private collaborations, real-world data, innovative study designs and policy implementation. Her experience in business development and finance adds a unique perspective to large scale scientific collaborations and initiatives. Prior to joining pharma, Pam was institutional investor in New York and Chicago. She has an MBA from Harvard Business School.